Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1
Laura Gieldon(Heidelberg University), Barbara Klink(German Cancer Research Center), Roland Därr(University of Freiburg), Karl Hackmann(Technische Universität Dresden), Evelin Schröck(German Cancer Research Center), Graeme Eisenhofer(University Hospital Carl Gustav Carus), Andrzej Januszewicz(Hypertension Institute), Daniela E. Aust(University Hospital Carl Gustav Carus), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Aleksander Prejbisz(Institute of Cardiology), Andreas Rump(VKTA), Andreas Tzschach(Max Planck Institute for Molecular Genetics), Susan Richter(University of Auckland), Silke Zeugner(University Hospital Carl Gustav Carus), Jimmy Masjkur(University Hospital Carl Gustav Carus), Marcos Lahera(Hospital Universitario de La Princesa)
Cited by 24
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394